A carregar...
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
BACKGROUND: It has been recognized that primary membranous nephropathy (MN) is related to an increased risk for thromboembolic complications. However, the current evidence supporting prophylactic and therapeutic anticoagulation is too weak to better meet the clinical needs of this patient population...
Na minha lista:
| Publicado no: | BMC Nephrol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889582/ https://ncbi.nlm.nih.gov/pubmed/31791286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1637-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|